Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Xiaoyi Wang & Hong Gao. (2020) Prevention of preeclampsia in high-risk patients with low-molecular-weight heparin: a meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine 33:13, pages 2202-2208.
Read now
Read now
Cihan Karadağ, Bertan Akar, Gökçenur Gönenç, Reyhan Aslancan, Nagihan Yılmaz & Eray Çalışkan. (2020) Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation. The Journal of Maternal-Fetal & Neonatal Medicine 33:11, pages 1934-1939.
Read now
Read now
Yeon Mee Kim, Piya Chaemsaithong, Roberto Romero, Majid Shaman, Chong Jai Kim, Jung-Sun Kim, Faisal Qureshi, Suzanne M. Jacques, Ahmed I. Ahmed, Tinnakorn Chaiworapongsa, Sonia S. Hassan, Lami Yeo & Steven J. Korzeniewski. (2015) Placental lesions associated with acute atherosis. The Journal of Maternal-Fetal & Neonatal Medicine 28:13, pages 1554-1562.
Read now
Read now
Nada Aracic, Damir Roje, Irena Drmic Hofman, Vesna Capkun & Vedran Stefanovic. (2015) Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome. The Journal of Maternal-Fetal & Neonatal Medicine 28:3, pages 306-310.
Read now
Read now
Tracy E. Dudding & John Attia. (2012) Maternal factor V Leiden and adverse pregnancy outcome: deciding whether or not to test. The Journal of Maternal-Fetal & Neonatal Medicine 25:7, pages 889-894.
Read now
Read now
Articles from other publishers (25)
Yan Chen, Tingting Wang, Xiaoling Liu, Changxiang Ye, Dexiu Xing, Rong Wu, Fang Li & Lizhang Chen. (2022) Low molecular weight heparin and pregnancy outcomes in women with inherited thrombophilia: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research 48:8, pages 2134-2150.
Crossref
Crossref
Mai M. Shaker, Manal M. Thomas & Taghreed A. Shalabi. (2021) Evaluating the role of inherited thrombophilia genes with recurrent pregnancy loss among Egyptian couples. Gene Reports 25, pages 101355.
Crossref
Crossref
Alessandra Bettiol, Laura Avagliano, Niccolò Lombardi, Giada Crescioli, Giacomo Emmi, Maria Letizia Urban, Gianni Virgili, Claudia Ravaldi & Alfredo Vannacci. (2021) Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta‐Analysis. Clinical Pharmacology & Therapeutics 110:1, pages 189-199.
Crossref
Crossref
Chanel C. La, Lily E. Takeuchi, Srinivas Abbina, Sreeparna Vappala, Usama Abbasi & Jayachandran N. Kizhakkedathu. (2020) Targeting Biological Polyanions in Blood: Strategies toward the Design of Therapeutics. Biomacromolecules 21:7, pages 2595-2621.
Crossref
Crossref
Stefan Dugalic, Milos Petronijevic, Aleksandar Stefanovic, Katarina Stefanovic, Svetlana Vrzic Petronijevic, Dejana Stanisavljevic, Sonja Perkovic Kepeci, Nemanja Milincic, Igor Pantic & Milan Perovic. (2019) Comparison of 2 approaches in management of pregnant women with inherited trombophilias. Medicine 98:34, pages e16883.
Crossref
Crossref
Livia Florentina Trasca, Natalia Patrascu, Ramona Bruja, Octavian Munteanu, Monica Cirstoiu & Dragos Vinereanu. (2019) Therapeutic Implications of Inherited Thrombophilia in Pregnancy. American Journal of Therapeutics 26:3, pages e364-e374.
Crossref
Crossref
M. Fernández Arias, E. Mazarico, A. Gonzalez, M. Muniesa, C. Molinet, L. Almeida & M. D. Gómez Roig. (2019) Genetic risk assessment of thrombophilia in patients with adverse obstetric outcomes. PLOS ONE 14:2, pages e0211114.
Crossref
Crossref
C. Karadağ, T. Yoldemir, S. D. Karadağ, C. İnan, Z. N. Dolgun & L. Aslanova. (2017) Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia. Irish Journal of Medical Science (1971 -) 186:3, pages 707-713.
Crossref
Crossref
Julia Unterscheider, Stefan C Kane, Briony Cutts, Helen Savoia & Joanne M Said. (2017) The role of thrombophilia testing in women with adverse pregnancy outcomes. The Obstetrician & Gynaecologist 19:2, pages 163-172.
Crossref
Crossref
Michael K. Bohlmann. 2017. Fehlgeburten Totgeburten Frühgeburten. Fehlgeburten Totgeburten Frühgeburten
317
321
.
R.E. Scharf & M.A. Pestka. 2017. Weiterbildung Gynäkologie und Geburtshilfe. Weiterbildung Gynäkologie und Geburtshilfe
97
112
.
Nada AracicDamir RojeIvana Alujevic JakusMarinela BakotinVedran Stefanovic. (2016) The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome. Yonsei Medical Journal 57:5, pages 1230.
Crossref
Crossref
O. A. Melkozerova, N. V. Bashmakova, E. V. Volkova, T. B. Tretyakova & G. N. Chistyakova. (2016) Genetic aspects of fetal programming of abnormal uterine bleeding in puberty: the role of endothelial disfunction. Problemy reproduktsii 22:3, pages 28.
Crossref
Crossref
Sandra A. Lowe, Lucy Bowyer, Karin Lust, Lawrence P. McMahon, Mark Morton, Robyn A. North, Michael Paech & Joanne M. Said. (2015) SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Australian and New Zealand Journal of Obstetrics and Gynaecology 55:5, pages e1-e29.
Crossref
Crossref
A.E.P. Heazell, S.A. Worton, L.E. Higgins, E. Ingram, E.D. Johnstone, R.L. Jones & C.P. Sibley. (2015) IFPA Gábor Than Award Lecture: Recognition of placental failure is key to saving babies' lives. Placenta 36, pages S20-S28.
Crossref
Crossref
R.E. Scharf & M.-A. Pestka. (2015) Venöse Thromboembolien, Thrombophilie und Thromboseprophylaxe in Gynäkologie und GeburtshilfePharmacological thromboprophylaxis in gynecology and obstetrics. Der Gynäkologe 48:4, pages 311-328.
Crossref
Crossref
Alessandro Ghidini. (2014) Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation. Prenatal Diagnosis 34:7, pages 649-654.
Crossref
Crossref
Wee-Shian Chan, Evelyne Rey, Nancy E. Kent, Wee-Shian Chan, Nancy E. Kent, Evelyne Rey, Thomas Corbett, Michèle David, M. Joanne Douglas, Paul S. Gibson, Laura Magee, Marc Rodger & Reginald E. Smith. (2014) Venous Thromboembolism and Antithrombotic Therapy in Pregnancy. Journal of Obstetrics and Gynaecology Canada 36:6, pages 527-553.
Crossref
Crossref
Henning Hagmann, Verena Bossung, Abdel Ali Belaidi, Alexander Fridman, S. Ananth Karumanchi, Ravi Thadhani, Bernhard Schermer, Peter Mallmann, Guenter Schwarz, Thomas Benzing & Paul T. Brinkkoetter. (2014) Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination. PLoS ONE 9:1, pages e85258.
Crossref
Crossref
R. E. Scharf & M. A. Pestka. (2017) Medikamentöse Thromboembolie-Prophylaxe in Gynäkologie und Geburtshilfe. Hämostaseologie 34:04, pages 277-288.
Crossref
Crossref
Rolf Becker, Thomas Keller, Holger Kiesewetter, Heiner Fangerau & Uta Bittner. (2013) Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects. Archives of Gynecology and Obstetrics 288:1, pages 41-48.
Crossref
Crossref
Nazli Hossain & Michael J. Paidas. (2013) Inherited Thrombophilia. Clinics in Laboratory Medicine 33:2, pages 377-390.
Crossref
Crossref
W. Rath & C. J. Thaler. (2017) Hereditäre Thrombophilien und Plazenta-medierte Schwangerschafts-komplikationen im II./III. Trimenon. Hämostaseologie 33:01, pages 21-36.
Crossref
Crossref
J.I.P. DE VRIES, M.G. VAN PAMPUS, W.M. HAGUE, P.D. BEZEMER & J.H. JOOSTEN. (2012) Low‐molecular‐weight heparin added to aspirin in the prevention of recurrent early‐onset pre‐eclampsia in women with inheritable thrombophilia: the FRUIT‐RCT. Journal of Thrombosis and Haemostasis 10:1, pages 64-72.
Crossref
Crossref
John C. P. Kingdom & Sascha Drewlo. (2011) Is heparin a placental anticoagulant in high-risk pregnancies?. Blood 118:18, pages 4780-4788.
Crossref
Crossref